Thank you for standing by. Welcome to the CorVel Corporation quarterly earnings release webcast. During the course of this webcast, CorVel Corporation may make projections or other forward-looking statements regarding future events or the future financial performances of the company. CorVel wishes to caution you that these statements are only predictions and that actual events or results may differ materially. CorVel refers you to the documents the company files from time to time with the Securities and Exchange Commission, specifically the company's last Form 10-K and 10-Q files for the most recent fiscal year and quarter. These documents contain and identify important factors that could cause the actual results to differ materially from those contained in our projections or forward-looking statements. I would now like to turn the call over to Mr. Michael Combs, Chief Executive Officer and President.

Good morning. Thank you for joining us to review CorVel's December quarter. On the call with me today is Brandon O’Brien, CorVel's Chief Financial Officer. Today, I will discuss business performance, the current environment, market trends and the progress we've achieved with our systems development. Brandon will then provide additional details on the financial results for the December quarter. The December quarter revenues were $179 million, 9% over the $165 million of revenue for the December 2021 quarter. Earnings per share for the quarter were $0.96, increasing 25% from $0.76 per share in the same quarter of the prior year. The results for the December quarter reflect the progress made addressing the staffing imbalances, which I reviewed in the prior release. The improvements have been achieved while prioritizing the quality and consistency of the work we perform for our partners. CorVel's development road map includes increased automation and augmentation, which will further optimize bottom line results and improve the outcomes we deliver. CERiS, which serves the commercial health market contributed strong results for the quarter. The results were achieved despite temporarily reduced transaction volume from key partners early in the quarter due to adjustments to the client's internal workflow processes. The reduction in volume experienced is appropriately categorized as deferred work, which we expect to process in the coming quarters. The workers' compensation markets for managed care and claims management remain active. Our Enterprise Comp claims management solution benefited from increasing market recognition of the results being achieved for our partners. Calendar year 2022 was significant as we reached record new sales as well as record revenues for the EC business. We were also recognized by Business Insurance for the Innovation Award of the Year as well as TPA Team of the Year. Investments in system enhancements for the managed…

This concludes today's webcast. You may disconnect your lines at this time.